Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease

DOI: 
10.1016/j.mehy.2015.06.023
Author: 
Quimby, K. R.;Hambleton, I. R.;Landis, R. C.
Back to top